Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03747146 · ClinicalTrials.gov registry record · NA

Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

A NA study of Anesthesia, sponsored by Hospital for Special Surgery, New York.

Recruiting
Registry status
NA
Development phase
94
Enrollment target
1
Study location

NCT03747146 is a NA study of Anesthesia that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 94 participants, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03747146, a NA study of Anesthesia, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.

RECRUITING
Registry status
NA
Development phase
94 participants
Enrollment target
1
Study location

Study Summary

A comparison of two anesthetic techniques for total knee replacements: (1) Peri-Articular Injection (PAI), local infiltration between the popliteal artery and capsule of the knee block (IPACK) and single-shot adductor canal block (ACB) vs. (2) PAI, IPACK and continuous adductor canal block catheter (ACC).

Conditions Studied

Interventions

  • DEVICE Continuous Adductor Canal Catheter (ACC)
  • DEVICE Adductor Canal block with sham catheter

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2018-11-16
Est. Completion 2026-12
Phase NA

What the Registry Record Tells You About NCT03747146

The ClinicalTrials.gov registry entry for NCT03747146 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Continuous Adductor Canal Catheter (ACC) is the first listed.

NCT03747146 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03747146 about?

NCT03747146 is a clinical study titled "Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service". A comparison of two anesthetic techniques for total knee replacements: (1) Peri-Articular Injection (PAI), local infiltration between the popliteal artery and capsule of the knee block (IPACK) and single-shot adductor canal block (ACB) vs. (2) PAI, IPACK and continuous adductor canal block catheter ...

What is the current status of trial NCT03747146?

This trial is currently recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2018-11-16. Estimated completion is 2026-12.

What conditions does trial NCT03747146 study?

This clinical trial studies the following conditions: Anesthesia.

What interventions are being tested in trial NCT03747146?

The interventions under investigation include: Continuous Adductor Canal Catheter (ACC) (DEVICE), Adductor Canal block with sham catheter (DEVICE).

Who is sponsoring clinical trial NCT03747146?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03747146 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.